Detalhe da pesquisa
1.
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
Cell
; 184(9): 2362-2371.e9, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735608
2.
Rapid development and mass production of SARS-CoV-2 neutralizing chicken egg yolk antibodies with protective efficacy in hamsters.
Biol Res
; 57(1): 24, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711133
3.
Novel hKDR mouse model depicts the antiangiogenesis and apoptosis-promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2.
Cancer Sci
; 114(1): 115-128, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114822
4.
Antitumor activity of pegylated human interferon ß as monotherapy or in combination with immune checkpoint inhibitors via tumor growth inhibition and dendritic cell activation.
Cell Immunol
; 393-394: 104782, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931572
5.
Validation of Luminex immunological and competitive Luminex immunological assays for clinical immunogenicity assessment of a 14-valent recombinant human papillomavirus vaccine.
J Med Virol
; 95(8): e29050, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635425
6.
Rapid and Quantitative In Vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies.
Anal Chem
; 94(10): 4504-4512, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238533
7.
Immunogenicity correlation in cynomolgus monkeys between Luminex-based total IgG immunoassay and pseudovirion-based neutralization assay for a 14-valent recombinant human papillomavirus vaccine.
J Med Virol
; 94(8): 3946-3955, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35388509
8.
Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer: a phase I dose-escalation and dose-expansion study.
BMC Cancer
; 22(1): 1104, 2022 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307775
9.
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera® ) in combination with CHOP in patients with previously untreated CD20-positive diffuse large B-cell lymphoma: A randomized, single-blind, phase III clinical trial.
Hematol Oncol
; 40(5): 930-940, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858181
10.
Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.
Haemophilia
; 28(6): e199-e208, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802040
11.
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys.
Pharm Res
; 39(9): 2191-2201, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35882740
12.
A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera®) in patients with CD20-positive B-cell non-Hodgkin lymphoma.
Chin J Cancer Res
; 34(6): 601-611, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36714342
13.
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study.
Antimicrob Agents Chemother
; 65(11): e0106321, 2021 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491805
14.
Pharmacokinetic, efficacy and safety evaluation of B-domain-deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A.
Haemophilia
; 27(5): 814-822, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089210
15.
Pharmacokinetics and pharmacodynamics of SCT800, a new recombinant FVIII, in hemophilia A mice.
Acta Pharmacol Sin
; 37(3): 408-14, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26806305
16.
Identification of Epitopes for Neutralizing Antibodies Against H10N8 Avian Influenza Virus Hemagglutinin.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 38(4): 404-10, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27594152
17.
Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma.
Chin J Cancer Res
; 28(2): 197-208, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27199517
18.
Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial.
Vaccines (Basel)
; 12(2)2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400158
19.
Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase â ¡ study.
EBioMedicine
; 100: 104966, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38217945
20.
[Eukaryotic expression and biological activity of human interleukin-35].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 35(6): 618-22, 2013 Dec.
Artigo
em Chinês
| MEDLINE | ID: mdl-24382238